Young adult oncology: The patients and their survival challenges

CA Cancer Journal for Clinicians

Volumn 57, Issue 4, 2007, Pages 242-255

  Bleyer, Archie ^a,b,c,d  

^a ST CHARLES MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d CureSearch/National Childhood Cancer Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; BRAIN TUMOR; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DOSE RESPONSE; DRUG TOLERABILITY; ECONOMIC ASPECT; ENVIRONMENTAL FACTOR; EWING SARCOMA; HEALTH CARE FACILITY; HEALTH INSURANCE; HODGKIN DISEASE; HUMAN; LEUKEMIA; MEDICAL SPECIALIST; MELANOMA; NONHODGKIN LYMPHOMA; ONCOLOGY; OSTEOSARCOMA; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; SOFT TISSUE SARCOMA; SPINAL CORD TUMOR; TESTIS CANCER; THYROID CANCER; TREATMENT OUTCOME; UTERINE CERVIX CANCER; ADOLESCENT; ADULT; AGE; ECONOMICS; HEALTH CARE QUALITY; INCIDENCE; MORTALITY; NEOPLASM; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK FACTOR; STANDARD; SURVIVAL; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; HUMANS; INCIDENCE; MEDICAL ONCOLOGY; NEOPLASMS; QUALITY OF HEALTH CARE; QUALITY OF LIFE; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 34447115880     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/canjclin.57.4.242     Document Type: Review

References (56)

1. Bleyer A, Albritton K, Ries LAG, Barr R. Introduction, in Bleyer A, Barr R, Albritton K, et al. (eds). Cancer in Adolescents and Young Adults. Heidelburg, Germany: Springer Verlag. In press.
2. Bleyer WA, O'Leary M, Barr R, Ries LAG (eds). Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006.
3. Adolescent and Young Adult Oncology Progress Review Group. Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, and the LiveStrong Young Adult Alliance. Available at: http://planning.cancer.gov/disease/AYAO_PRG_Report_2006_FINAL.pdf. Accessed April 23, 2007.
4. Bleyer A, Albritton K. Cancer in the young adult and adolescent, in Kufe DW, Pollock RE, Weichselbaum RR, et al. (eds). Holland-Frei: Cancer Medicine. 7th ed. Hamilton, Ontario: BC Decker; 2006:2028-2036.
5. National Cancer Institute, U.S. National Institutes of Health. Surveillance, Epidemiology, and End Results (SEER) Program. Available at: www.seer.cancer.gov. Accessed February 4, 2007.
6. Melnick S, Cole P, Anderson D, Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med 1987;316:514-519.
7. US Census Bureau. Annual Estimates of the Population for the United States, Regions, States, and for Puerto Rico: April 1, 2000 to July 1, 2006 (NST-EST2006-01). Available at: http://www.census.gov/popest/states/NST-ann-est. html. Accessed February 4, 2007.
8. Palmer JR, Wise LA, Hatch EE, et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1509-1514.
9. Jarrett RF. Viruses and lymphoma/leukaemia. J Pathol 2006;208:176-186.
10. American Cancer Society. Signs and Symptoms of Cancer. Available at: http://www.cancer.org/docroot/CRI/content/ CRI_2_4_3X_What_are_the_signs_and_symptoms_of_cancer.asp?sitearea. Accessed April 23, 2007.
11. Bleyer A. Principles of diagnosis, in Behrman RE, Kliegman RM, Jenson HB (eds). Nelson's Textbook of Pediatrics. 17th ed. Philadelphia, PA: Saunders; 2003:1684-1688.
12. Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr 1991;119:725-732.
13. Bleyer A, Ulrich C, Martin S, et al. Status of health insurance predicts time from symptom onset to cancer diagnosis (TDx) in young adults [abstract]. Proc Am Soc Clin Oncol 2005;23:547S. Abstract 6079.
14. Martin S, Ulrich C, Munsell M, et al. Time to cancer diagnosis in young Americans depends on type of cancer and health insurance status. Value in Health 2005;8:344.
15. Ziv A, Boulet JR, Slap GB. Utilization of physician offices by adolescents in the United States. Pediatrics 1999;104:35-42.
16. McCormick MC, Kass B, Elixhauser A, et al. Annual report on access to and utilization of health care for children and youth in the United States - 1999. Pediatrics 2000;105:219-230.
17. Office of Technology Assessment. Adolescent Health. Vol I: Summary and Policy Options. Washington, DC: US Government Printing Office; 1991.
18. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-169.
19. Jemal A. Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007.
20. Goldman S, Stafford C, Weinthal J, et al. Older adolescents vary greatly from children in their route of referral to the pediatric oncologist and national trials [abstract]. Proc Am Soc Clin Oncol 2000;18:18. Abstract 1766.
21. Albritton K, Wiggins CL. Adolescents with cancer are not referred to Utah's pediatric center [abstract]. Proc Am Soc Clin Oncol 2001;19:19. Abstract 990.
22. Klein-Geltink J, Shaw AK, Morrison HI, et al. Use of paediatric versus adult oncology treatment centres by adolescents 15-19 years old: the Canadian Childhood Cancer Surveillance and Control Program. Eur J Cancer 2005;41:404-410.
23. Rauck AM, Fremgen AM, Menck HR, et al. Adolescent cancers in the United States: a National Cancer Data Base (NCDB) report. J Pediatr Hematol Oncol 1999;21:310.
24. Stock W, Sather H, Dodge RK, et al. Outcome of adolescents and young adults with ALL: a comparison of Children's Cancer Group and Cancer and Leukemia Group B Regimens. Blood 2000;96:467a.
25. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003;21:774-780.
26. de Bont JM, Holt B, Dekker AW, et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 2004;18:2032-2035.
27. Schroeder H, Kjeldahl M, Boeson AM, et al. Prognosis of ALL in 10-20 year old patients in Denmark 1992-2001 [abstract]. Pediat Blood Cancer 2005;45:578.
28. Testi A. Difference in outcome of adolescents (14-17 years) with acute lymphoblastic leukemia (ALL) enrolled in the Italian pediatric (AIEOP) and adult (GIMEMA) multicenter protocols [abstract]. Proc Am Society Clin Oncol, J Clin Oncol 2006;24:18S. Abstract 9024.
29. Ramanujachar R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer 2007;48:254-261.
30. Ramanujachar R, Richards S, Hann I, Webb D. Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatr Blood Cancer 2006;47:748-756.
31. Paulussen S, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPO-HCESS/EICESS studies [abstract]. Proc Amer Soc Clin Oncol 2003;22:22. Abstract 816.
32. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 2003;98:571-580.
33. Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000;18:547-561.
34. Lewis IJ. Cancer in adolescence. Br Med Bull 1996;52:887-897.
35. Clemons M, Loijens L, Goss P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev 2000;26:291-302.
36. Festa RS, Tamaroff MH, Chasalow F, Lanzkowsky P. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr 1992;120:807-811.
37. Tamaroff MH, Festa RS, Adesman AR, Walco GA. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr 1992;120:813-817.
38. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer 1993;71(suppl):3441-3449.
39. Kyngas HA, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: a review. J Adolesc Med 2000;26:379-388.
40. Bleyer WA. Delayed toxicities of chemotherapy on childhood tissues: 1981 update. Front Radiat Ther Oncol 1981;16:50-54.
41. Verrill MW, Judson IR, Wiltshaw E, et al. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol 1997;8:1099-1105.
42. Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 1997;21:366-373.
43. Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 2005;23:8884-8893.
44. Schover LR, Brey K, Lichtin A, et al. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002;20:1880-1889.
45. Koocher GP, O'Malley JE. The Damocles Syndrome: Psychosocial Consequences of Surviving Childhood Cancer. New York, NY: McGraw-Hill; 1981.
46. Hays DM, Landsverk J, Sallan SE, et al. Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol 1992;10:1397-1406.
47. Hoyert DL, Kung HC, Smith BL. Deaths: preliminary data for 2003. Natl Vital Stat Rep 2005;53:1-48.
48. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
49. Bleyer A, Barr R. Challenges and opportunities, in Bleyer A, Barr R, Albritton K, et al. (eds). Cancer in Adolescents and Young Adults. Heidelburg, Germany: Springer Verlag. In press.
50. Molassiotis A, Scott JA, Kearney N, et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 2006;14:260-267.
51. Cassileth BR, Deng G. Integrative oncology: complementary therapies in cancer care, in Kufe DW, Pollock RE, Weichselbaum RR, et al. (eds). Holland-Frei: Cancer Medicine. 7th ed. Hamilton, Ontario: BC Decker; 2006:957-965.
52. Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 2007 Mar 13;[Epub ahead of print]
53. D'Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005;55:319-321.
54. Lance Armstrong Foundation. LIVESTRONG Young Adult Alliance. Available at: www.livestrong.org/site/c.jvKZLbMRIsG/b.865471/k.B49/Young_Adult_Alliance. htm. Accessed April 24, 2007.
55. Barr RD. On cancer control and the adolescent. Med Pediatr Oncol 1999;32:404-410.
56. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007;57:90-104.